Exchange: NYSE·Updated 11:49 AM EST

PFE News

News
all
press releases
The Zacks Analyst Blog Highlights Visa, ExxonMobil Holdings and Pfizer
Visa, ExxonMobil Holdings and Pfizer are included in this Analyst Blog.
Zacks
The Zacks Analyst Blog Highlights Visa, ExxonMobil Holdings and Pfizer
Visa, ExxonMobil Holdings and Pfizer are included in this Analyst Blog.
Zacks
More News
Key PointsNovo Nordisk A/S maintains a leading position in the high-growth obesity and diabetes treatment markets...
Nasdaq News: Markets
Large drugmakers and specialized investors continued to favor targeted capability additions, asset purchases, and co-funding arrangements over outright buyouts of late-stage biotechs this week.
Stocktwits
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), ExxonMobil Holdings Corporation (XOM) and Pfizer Inc. (PFE).
Zacks
MRNA shares fall as 2027 cost projections raise concerns, while limited visibility into future revenue growth weighs on investor sentiment.
Zacks
PFE shares fell despite the company beating Q3 estimates and raising guidance. Explore its growth drivers, pipeline potential, patent risks & attractive valuation.
Zacks
Key PointsDrugmaker Pfizer has a brighter future than its stock's recent performance suggests. You just need to look a little further down the road than most investors typically do...
Nasdaq News: Markets
Moderna's 3% post-earnings gain reflects stronger overseas COVID-19 sales and higher 2026 guidance, while oncology advances offer growth potential.
Zacks
Investors in Pfizer Inc (Symbol: PFE) saw new options become available today, for the December 31st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options chain for the new December 31st contracts and identified one put and one call...
Nasdaq News: Markets
Pfizer and Blackstone Life Sciences signed a $1.5 billion deal to fund berobenatide, a monthly GLP-1 obesity drug entering 10 Phase 3 trials in 2026.read more...
Benzinga

Advertisement|Remove ads.